Skip to main content
x
Dartmouth-Hitchcock logo
Summer Flowers In This Section
 
Induction Study #2 - A Phase 3, Multicenter, Randomized, Double-Blind,Placebo-Controlled Study Of Oral Ozanimod As Induction Therapy For Moderately To Severely Active Crohn's Disease
Principal Investigator (?)
Study Number
F18076
Summary
This is a Phase 3, randomized, double-blind, placebo-controlled study to explore the effect of oral ozanimod as an induction treatment for subjects with moderately to severely active Crohn''s Disease. 
Phase (?)
Phase III
Sponsor (?)
Contact

Jessica Chevalier

Available at the following location(s)

Lebanon

View more details from ClinicalTrials.gov.

0